Stay updated on Tolebrutinib in NRSPMS Clinical Trial

Sign up to get notified when there's something new on the Tolebrutinib in NRSPMS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tolebrutinib in NRSPMS Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Two study location entries in India (122001 and 122002) were updated from Gurgaon to the diacritic spelling Gūrgaon in the study's locations list.
    Difference
    0.1%
    Check dated 2026-02-02T19:57:01.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    Glossary display toggle has been added to the page. Updated labels and revision information include 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and a revision note 'v3.4.0' replacing the previous 'v3.3.4'.
    Difference
    0.1%
    Check dated 2026-01-26T22:18:54.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4; no visible edits to the study details or page functionality.
    Difference
    0.0%
    Check dated 2026-01-19T19:02:08.000Z thumbnail image
  4. Check
    47 days ago
    Change Detected
    Summary
    The Locations section has been updated with numerous new trial sites across the US, Argentina, Australia, Canada, India, and Europe. Several previously listed locations were removed.
    Difference
    2%
    Check dated 2025-12-22T01:31:57.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Two India locations (122001 and 122002) updated from Gurgaon to Gūrgaon to reflect the city’s diacritic spelling.
    Difference
    0.0%
    Check dated 2025-12-14T23:55:54.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    Revision updated from v3.3.1 to v3.3.2 on the page.
    Difference
    0.0%
    Check dated 2025-11-30T11:48:19.000Z thumbnail image

Stay in the know with updates to Tolebrutinib in NRSPMS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tolebrutinib in NRSPMS Clinical Trial page.